Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas’ disease
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
A century after its discovery, Chagas’ disease still represents a major public health challenge in Latin America. Moreover, because of growing population movements, an increasing number of cases of imported Chagas’ disease have now been detected in non-endemic areas, such as North America and some European countries. This parasitic zoonosis, caused by Trypanosoma cruzi, is transmitted to humans by infected Triatominae insects, or occasionally by non-vectorial mechanisms, such as blood transfusion, mother to fetus, or oral ingestion of materials contaminated with parasites. Following the acute phase of the infection, untreated individuals enter a chronic phase that is initially asymptomatic or clinically unapparent. Usually, a few decades later, 40–50% of patients develop progressive cardiomyopathy and/or motility disturbances of the oesophagus and colon. In the last decades several interventions targeting primary, secondary and tertiary prevention of Chagas’ disease have been attempted. While control of both vectorial and blood transfusion transmission of T cruzi (primary prevention) has been successful in many regions of Latin America, early detection and aetiological treatment of asymptomatic subjects with Chagas’ disease (secondary prevention) have been largely underutilised. At the same time, in patients with established chronic disease, several pharmacological and non-pharmacological interventions are currently available and have been increasingly used with the intention of preventing or delaying complications of the disease (tertiary prevention). In this review we discuss in detail each of these issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Bank, W. (1993) · doi:10.1596/978-0-1952-0890-0 · Cited by 1,048
Cited by
Rassi, A., Rassi, A., & Marin-Neto, J. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60061-x · Cited by 2,119
Self-citationGarvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Room Temperature Gas Sensing of Two-Dimensional Titanium Carbide (MXene)
Lee, E., VahidMohammadi, A., Prorok, B. C., Yoon, Y. S., Beidaghi, M., & Kim, D.-J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b11055 · Cited by 878
Bern, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1410150 · Cited by 770
AMERICAN TRYPANOSOMIASIS (CHAGAS' DISEASE): FIRST INDIGENOUS CASE IN THE UNITED STATES
Woody, N. C. (1955) · Journal of the American Medical Association · doi:10.1001/jama.1955.02960240042010a · Cited by 533
Metadata
- Authors
- Rassi, A., Dias, J. C. P., Marin-Neto, J. A., & Rassi, A.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2009-01-08
- Volume
- 95
- Issue
- 7
- Pages
- 524-534
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2099871562
- Cited by
- 140
- References
- 3
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas’ disease. https://app.cochat.ai/papers/10.1136/hrt.2008.159624
- The paper
- Rassi, A., Dias, J. C. P., Marin-Neto, J. A., & Rassi, A. (2009). Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas’ disease. Heart. https://doi.org/10.1136/hrt.2008.159624
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.